This past week I sold my entire position in Crescita Therapeutics. In Q3 Crescita collected a $5 million royalty payment that was owed to them by Taro Pharmaceuticals. The collection…
On August 11th Crescita Q2 2020 financials were released. It was a difficult quarter for Crescita. In March Crescita closed its office and manufacturing facility in Quebec. Not only was…
For Part 1 of my Crescita analysis (CTX.TO, CRRTF) please read the previous post. I own shares of CTX.TO. Crescita Therapeutics (CTX.TO, CRRTF) is a publicly-traded, Canadian commercial dermatology company…
Here is my Q3 2019 portfolio update. At the end of each year, I will give a comparison of how my portfolio and each individual stock performed compared to the…
Crescita Therapeutics (TSX: CTX) is a publicly-traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions…